Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
Voltage-gated sodium channel β subunits (encoded by SCN1B to SCN4B genes) have been demonstrated as important multifunctional signaling molecules modulating cellular processes such as cell adhesion and cell migration. In this study, we aimed to explore the expression profiles of SCN4B in papillary t...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5933725?pdf=render |
id |
doaj-950406c17ab64d8bb2da2f291c502611 |
---|---|
record_format |
Article |
spelling |
doaj-950406c17ab64d8bb2da2f291c5026112020-11-25T01:17:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01135e019700710.1371/journal.pone.0197007Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.Yanping GongJing YangWenshuang WuFeng LiuAnping SuZhihui LiJingqiang ZhuTao WeiVoltage-gated sodium channel β subunits (encoded by SCN1B to SCN4B genes) have been demonstrated as important multifunctional signaling molecules modulating cellular processes such as cell adhesion and cell migration. In this study, we aimed to explore the expression profiles of SCN4B in papillary thyroid cancer (PTC) and its prognostic value in terms of recurrence-free survival (RFS) in classical PTC. In addition, we also examined the potential effect of DNA methylation on its expression. A retrospective study was performed by using data from available large databases, including the Gene Expression Omnibus (GEO) datasets and the Cancer Genome Atlas (TCGA)-Thyroid Cancer (THCA). Results showed that SCN4B is downregulated at both RNA and protein level in PTC compared with normal thyroid tissues. Preserved SCN4B expression was an independent indicator of favorable RFS in patients with classical PTC, no matter as categorical variables (HR: 0.243, 95%CI: 0.107-0.551, p = 0.001) or as a continuous variable (HR: 0.684, 95%CI: 0.520-0.899, p = 0.007). The methylation status of one CpG site (Chr11: 118,022,316-318) in SCN4B DNA had a moderately negative correlation with SCN4B expression in all PTC cases (Pearson's r = -0.48) and in classical PTC cases (Pearson's r = -0.41). In comparison, SCN4B DNA copy number alterations (CNAs) were not frequent and might not influence its mRNA expression. In addition, no somatic mutation was found in SCN4B DNA. Based on these findings, we infer that preserved SCN4B expression might independently predict favorable RFS in classical PTC. Its expression might be suppressed by DNA hypermethylation, but is less likely to be influenced by DNA CNAs/mutations.http://europepmc.org/articles/PMC5933725?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yanping Gong Jing Yang Wenshuang Wu Feng Liu Anping Su Zhihui Li Jingqiang Zhu Tao Wei |
spellingShingle |
Yanping Gong Jing Yang Wenshuang Wu Feng Liu Anping Su Zhihui Li Jingqiang Zhu Tao Wei Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer. PLoS ONE |
author_facet |
Yanping Gong Jing Yang Wenshuang Wu Feng Liu Anping Su Zhihui Li Jingqiang Zhu Tao Wei |
author_sort |
Yanping Gong |
title |
Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer. |
title_short |
Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer. |
title_full |
Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer. |
title_fullStr |
Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer. |
title_full_unstemmed |
Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer. |
title_sort |
preserved scn4b expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
Voltage-gated sodium channel β subunits (encoded by SCN1B to SCN4B genes) have been demonstrated as important multifunctional signaling molecules modulating cellular processes such as cell adhesion and cell migration. In this study, we aimed to explore the expression profiles of SCN4B in papillary thyroid cancer (PTC) and its prognostic value in terms of recurrence-free survival (RFS) in classical PTC. In addition, we also examined the potential effect of DNA methylation on its expression. A retrospective study was performed by using data from available large databases, including the Gene Expression Omnibus (GEO) datasets and the Cancer Genome Atlas (TCGA)-Thyroid Cancer (THCA). Results showed that SCN4B is downregulated at both RNA and protein level in PTC compared with normal thyroid tissues. Preserved SCN4B expression was an independent indicator of favorable RFS in patients with classical PTC, no matter as categorical variables (HR: 0.243, 95%CI: 0.107-0.551, p = 0.001) or as a continuous variable (HR: 0.684, 95%CI: 0.520-0.899, p = 0.007). The methylation status of one CpG site (Chr11: 118,022,316-318) in SCN4B DNA had a moderately negative correlation with SCN4B expression in all PTC cases (Pearson's r = -0.48) and in classical PTC cases (Pearson's r = -0.41). In comparison, SCN4B DNA copy number alterations (CNAs) were not frequent and might not influence its mRNA expression. In addition, no somatic mutation was found in SCN4B DNA. Based on these findings, we infer that preserved SCN4B expression might independently predict favorable RFS in classical PTC. Its expression might be suppressed by DNA hypermethylation, but is less likely to be influenced by DNA CNAs/mutations. |
url |
http://europepmc.org/articles/PMC5933725?pdf=render |
work_keys_str_mv |
AT yanpinggong preservedscn4bexpressionisanindependentindicatoroffavorablerecurrencefreesurvivalinclassicalpapillarythyroidcancer AT jingyang preservedscn4bexpressionisanindependentindicatoroffavorablerecurrencefreesurvivalinclassicalpapillarythyroidcancer AT wenshuangwu preservedscn4bexpressionisanindependentindicatoroffavorablerecurrencefreesurvivalinclassicalpapillarythyroidcancer AT fengliu preservedscn4bexpressionisanindependentindicatoroffavorablerecurrencefreesurvivalinclassicalpapillarythyroidcancer AT anpingsu preservedscn4bexpressionisanindependentindicatoroffavorablerecurrencefreesurvivalinclassicalpapillarythyroidcancer AT zhihuili preservedscn4bexpressionisanindependentindicatoroffavorablerecurrencefreesurvivalinclassicalpapillarythyroidcancer AT jingqiangzhu preservedscn4bexpressionisanindependentindicatoroffavorablerecurrencefreesurvivalinclassicalpapillarythyroidcancer AT taowei preservedscn4bexpressionisanindependentindicatoroffavorablerecurrencefreesurvivalinclassicalpapillarythyroidcancer |
_version_ |
1725148876247138304 |